- Home
- AGRI vs ZVSA Comparison
AGRI vs ZVSA Comparison
Compare AGRI & ZVSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AGRI
- ZVSA
- Stock Information
- Founded
- AGRI 2017
- ZVSA 2014
- Country
- AGRI Canada
- ZVSA United States
- Employees
- AGRI N/A
- ZVSA N/A
- Industry
- AGRI
- ZVSA Biotechnology: Pharmaceutical Preparations
- Sector
- AGRI
- ZVSA Health Care
- Exchange
- AGRI Nasdaq
- ZVSA Nasdaq
- Market Cap
- AGRI 3.6M
- ZVSA 3.5M
- IPO Year
- AGRI 2021
- ZVSA N/A
- Fundamental
- Price
- AGRI $1.66
- ZVSA $1.22
- Analyst Decision
- AGRI
- ZVSA Strong Buy
- Analyst Count
- AGRI 0
- ZVSA 1
- Target Price
- AGRI N/A
- ZVSA $240.00
- AVG Volume (30 Days)
- AGRI 149.0K
- ZVSA 69.7K
- Earning Date
- AGRI 03-31-2025
- ZVSA 03-24-2025
- Dividend Yield
- AGRI N/A
- ZVSA N/A
- EPS Growth
- AGRI N/A
- ZVSA N/A
- EPS
- AGRI N/A
- ZVSA N/A
- Revenue
- AGRI $57,596.00
- ZVSA N/A
- Revenue This Year
- AGRI $280,570.72
- ZVSA N/A
- Revenue Next Year
- AGRI $696.48
- ZVSA N/A
- P/E Ratio
- AGRI N/A
- ZVSA N/A
- Revenue Growth
- AGRI N/A
- ZVSA N/A
- 52 Week Low
- AGRI $1.58
- ZVSA $0.98
- 52 Week High
- AGRI $22.40
- ZVSA $25.00
- Technical
- Relative Strength Index (RSI)
- AGRI 30.25
- ZVSA 44.26
- Support Level
- AGRI $1.58
- ZVSA $1.12
- Resistance Level
- AGRI $1.94
- ZVSA $1.29
- Average True Range (ATR)
- AGRI 0.17
- ZVSA 0.09
- MACD
- AGRI -0.01
- ZVSA -0.01
- Stochastic Oscillator
- AGRI 10.99
- ZVSA 37.04
About AGRI AgriFORCE Growing Systems Ltd.
AgriFORCE Growing Systems Ltd is an Ag-Tech company with a primary focus on developing and utilizing its intellectual property assets for improvements dedicated to the agricultural industry. The company believes that this goal is best achieved by using its proprietary IP for solutions in the agricultural industry as well as seeking the development of new IP to both enhance the technology which it has already retained in-house as well as development of new technologies which can increase its footprint in the Ag-Tech space. Its AgriFORCE Brands division is focused on the development and commercialization of plant-based ingredients and products that deliver more nutritious food. It will market and commercialize ingredient supplies, like its Awakened Flour and Awakened Grains.
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.